Novel animal models of acetylcholine receptor antibody-related myasthenia gravis.

about

IgG1 deficiency exacerbates experimental autoimmune myasthenia gravis in BALB/c mice S1P receptor antagonists fingolimod and siponimod do not improve the outcome of experimental autoimmune myasthenia gravis mice after disease onset.

P2860

Q35400161-2C14C717-6AF3-4311-A795-0259472CE131 Q47368292-8DD2EE35-BA88-42F1-959D-E9FE6C82F0F7

P2860

Novel animal models of acetylcholine receptor antibody-related myasthenia gravis.

Item

http://www.wikidata.org/entity/Q38068536

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Novel animal models of acetylcholine receptor antibody-related myasthenia gravis.

@en

type

Item

label

Novel animal models of acetylcholine receptor antibody-related myasthenia gravis.

@en

prefLabel

Novel animal models of acetylcholine receptor antibody-related myasthenia gravis.

@en

P1476

Novel animal models of acetylcholine receptor antibody-related myasthenia gravis.

@en

P2093

Canan Ulusoy

http://www.w3.org/2001/XMLSchema#string

Erdem Tüzün

http://www.w3.org/2001/XMLSchema#string

Huan Yang

http://www.w3.org/2001/XMLSchema#string

Premkumar Christadoss

http://www.w3.org/2001/XMLSchema#string

Windy Allman

http://www.w3.org/2001/XMLSchema#string

P2860

Animal models of myasthenia gravis.

Acetylcholine receptor-alpha subunit expression in myasthenia gravis: a role for the autoantigen in pathogenesis?

Neuromuscular junction autoimmune disease: muscle specific kinase antibodies and treatments for myasthenia gravis.

Both CD4+ and CD8+ T cells are essential to induce experimental autoimmune myasthenia gravis.

Autoimmune disorders of the neuromuscular junction.

Complement and cytokine based therapeutic strategies in myasthenia gravis.

Classical complement pathway in experimental autoimmune myasthenia gravis pathogenesis.

A new mouse model of autoimmune ocular myasthenia gravis.

MRI and clinical studies of facial and bulbar muscle involvement in MuSK antibody-associated myasthenia gravis.

Bacterial lipopolysaccharide acts as an adjuvant to induce autoimmune arthritis in mice.

P304

133-139

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/J.1749-6632.2012.06773.X

http://www.w3.org/2001/XMLSchema#string

P407

English

P478

1274

http://www.w3.org/2001/XMLSchema#string

P577

2012-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

233956499

http://www.w3.org/2001/XMLSchema#string

P698

23252908

http://www.w3.org/2001/XMLSchema#string

P921

myasthenia gravis

Novel animal models of acetylcholine receptor antibody-related myasthenia gravis.

about

P2860

P2860

Novel animal models of acetylcholine receptor antibody-related myasthenia gravis.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P478

P577

P5875

P698

P921

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P478

P577

P5875

P698

P921